Protective Nasal Spray Developed Against Covid-19 Starts to Be Produced in TRNC

Protective nasal spray developed against covid is started to be produced when small
Protective nasal spray developed against covid is started to be produced when small

Near East University signed an agreement with the Italian MAGI Group to produce the Protective Nasal Spray in TRNC, of ​​which it is a project and patent partner. Protective Nasal Spray after completion of the permitting process, after Italy and Cyprus, Turkey and the Turkic Republics will be available in Covidien-19 to fight.

Near East University, Covidien-19 causing SARS-CoV-2 to prevent contamination of the cells to the protective Nasal Spray is developing the project partner, after Italy and Turkey, Italian MAG to provide for use in TRNC and Turkic Republics Group'l signed protocol . Fully Protective Nasal Spray produced from the natural components, which will be produced in the TRNC Near East University in the first place, the production aims to transfer to Turkey.

Protective Spray, which can be applied through the nose and mouth, prevents SARS-CoV-2 from binding to the cells in the upper respiratory tract on the one hand, and on the other hand, it provides a two-way protection by killing viruses with its antiviral effect. Protective Nasal Spray is also effective against viruses other than SARS-CoV-2.

The Protective Nasal Spray, developed in partnership with the Near East University, Perugia University, European Biotechnology Association (EBTNA) and the Italian MAGI Group, was started to be used in Italy in February in the fight against COVID-19. Near East University, producing the protective Nasal Spray in the TRNC and Turkey, then Italy, Cyprus, Turkey, and intends to launch in the Turkic Republics.

It neutralizes the virus with natural ingredients ...

Protective Nasal Spray, a product with natural ingredients, obtained from olive leaf extract, has receptor-blocking, anti-viral and anti-oxidant properties applied through the nose and mouth. It was determined that the spray did not cause toxic effects on cells, inhibits SARS-CoV-2 and has no side effects in laboratory and human experiments conducted in Italy and the Turkish Republic of Northern Cyprus.

Protective Nasal Spray, which is especially in the risk group and aims to protect contact persons from the virus, when applied through the nose and mouth, it provides a physical defense by creating a shield that will prevent viruses transmitted through the upper respiratory tract from entering the cells. It also prevents viruses from being contagious by inactivating them.

Protective Nasal Spray Developed Against COVID-19 Starts to Be Produced in TRNC Prof. Dr. İrfan Suat Günsel: "As Near East University, we will produce the Protective Nasal Spray with the vision of University 4.0 and make it available to our people."

Stating that the Protective Nasal Spray, which Near East University took part in the development process, made an important contribution to the fight against COVID-19, Near East University Chairman of the Board of Trustees Prof. Dr. İrfan Suat Günsel said, "As Near East University, we are proud to produce the Protective Nasal Spray with the vision of University 4.0 and offer it to the use of the Turkish people in the development and testing stages."

Protective Nasal Spray Developed Against COVID-19 Starts to Be Produced in TRNC Prof. Dr. Tamer Şanlıdağ: "Protective Nasal Spray provides dual protection against SARS-CoV-2"

Near East University Acting Rector Prof. Dr. Tamer Şanlıdağ emphasizes that the Protective Nasal Spray prevents the binding of SARS-CoV-19, which causes COVID-2, to cells, and on the other hand, it provides a two-way protection by killing viruses with its antiviral effect. Stating that they undertook the trials of the Protective Nasal Spray in the TRNC during the development phase, Prof. Dr. Şanlıdağ made the assessment that "The scientific studies we have conducted reveal that the Protective Nasal Spray, which is also used in Italy, will make an important contribution to the fight against the COVID-19 epidemic."

Armin

sohbet

Be the first to comment

Comments